Filing Details

Accession Number:
0001203311-23-000097
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-30 19:08:39
Reporting Period:
2023-08-28
Accepted Time:
2023-08-30 19:08:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741836 D Roger Dansey 21823 30Th Drive Se
Bothell WA 98021
President, R&D & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-28 1,872 $0.00 116,813 No 4 A Direct
Common Stock Disposition 2023-08-29 1,016 $206.00 115,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023.
  2. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  3. The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/13/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).